Drug intelligence / Profile preview

paracetamol + chlorpheniramine maleate + phenylephrine

Development stage
Unknown
Lead developer
Sarvajanik Pharmacy
Modality
Small Molecules
Administration
Oral
01

Overview

Paracetamol + chlorpheniramine maleate + phenylephrine is an approved oral small-molecule combination drug used to treat symptoms of the common cold, influenza, and allergic rhinitis, including nasal congestion, fever, headache, body aches, and sinus pressure. It contains three active ingredients: paracetamol (acetaminophen), an analgesic and antipyretic that inhibits prostaglandin synthesis in the central nervous system to relieve pain and reduce fever; phenylephrine, a sympathomimetic decongestant that stimulates alpha-1 adrenergic receptors to constrict blood vessels in the nasal mucosa, thereby relieving nasal congestion and sinus pressure; and chlorpheniramine maleate, a first-generation antihistamine that blocks H1 histamine receptors to alleviate allergy symptoms such as sneezing, runny nose, watery eyes, and itching.

Brand names
Alex P PaedAlerfriColdicareCoriminic PCozy-KidFebrex PlusKoldbayMaxtra PSneezdocSolvin ColdSumo Cold PcfTagorylTusQ-PZincold
Other names
acetaminophen + chlorpheniramine maleate + phenylephrineparacetamol + chlorpheniramine + phenylephrineparacetamol + chlorpheniramine maleate + phenylephrine hydrochlorideparacetamol, chlorpheniramine maleate, and phenylephrineparacetamol, chlorpheniramine maleate, and phenylephrine hydrochloride
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)HRH1 (Histamine H1 Receptor)ADRA1A (α1A)ADRA1D (α1D)ADRA1B (α1B)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on paracetamol + chlorpheniramine maleate + phenylephrine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on paracetamol + chlorpheniramine maleate + phenylephrine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call